The drug-named address serves a different drug
Two paths were requested: one naming compounded semaglutide, one naming compounded tirzepatide. Both were served the same dual-agonist page, identical in size and content.
That is not a broken link. It is a silent same-host rewrite, and the effect is that a reader following a semaglutide address reads a page about a different product with a different price ladder. Anyone recording the figures from that address would attribute dual-agonist pricing to semaglutide.
The single-agonist ladder does exist, at its own address, and it is cheaper at every step. Both ladders are recorded here, each against the address that actually served it.
Priced by class, not by molecule
Neither ladder names a molecule. The products are called a personalised GLP-1 and a personalised GLP-1/GIP with B12, and the doses are given in milligrams per week.
Twenty of the one hundred and fifty-eight sellers here put a price beside a product they will only call a GLP-1. A dose in milligrams is not a substitute for a drug name, because the same number of milligrams means different things for different molecules.
The ladders themselves are complete and clearly laid out, which makes the omission more conspicuous rather than less.
Two brands at one address
The product pages carry a street address and two telephone numbers, and also an email address belonging to a differently named business at the same street address. The site does not explain the relationship.
No operating entity is published. The terms page runs to more than thirty thousand characters of extracted text and refers only to the Company throughout.
No pharmacy is named, no individual clinician is named, and no service area is published.
Remi Meds's published pricing
| Medication | Price | Verified |
|---|---|---|
| Glp-1 (compounded) | $249/molowest step of the Personalized GLP-1 ladder, which continues 0.5 mg $289, 1 mg $329, 1.7 mg $345 and 2.4 mg $369; the seller labels the product by class rather than by drug name | September 2026source |
| Glp-1 (compounded) | $349/molowest step of the dual-agonist ladder, which continues 4.5 mg $379, 6.75 mg $429, 9 mg $549 and 11.25 mg $639. The URL that names compounded semaglutide and the URL that names compounded tirzepatide both resolve to this page, byte for byte | September 2026source |
compareglp may earn a commission when a reader signs up with a provider through a link on this site. 4 of the 158 providers reviewed here are paid partners today; the other 154 are not. See how this works.
See Remi Meds's current price →Good fit if
- Buyers who want a full dose ladder priced before starting.
- Readers comparing a single-agonist product against a dual-agonist one from the same seller.
- People who want a street address and a telephone number on the product page.
Look elsewhere if
- Anyone who needs to know which molecule they are buying; neither ladder names one.
- Readers navigating by drug-named URLs, which do not serve the drug they name.
- Buyers who want to know which company they are contracting with.
- People who need a service-area list.
How this review was verified
- Requested three product paths on 6 September 2026 and compared the requested path to the effective path on each; two of them were rewritten to the same dual-agonist page and returned identical byte counts.
- Ran a nonsense-path control on the host in the same run, which returned a clean not-found status.
- Recorded each ladder against the address that actually served it, not the address that was asked for.
- Read the terms page in full and searched it for any company name; only the generic Company appears.
- Screened the operating entity and the brand name against FDA's live warning-letter datatable, carrying a known letter as a positive control and a nonsense string as a negative control in the same pass; the positive control returned its letter and the negative returned nothing. Neither the entity nor the brand returned one. Untitled letters are published separately and were not searched, so the supportable claim is that no warning letter was found.